Finder Award
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Arcellx stock
Learn how to easily invest in Arcellx stock.
Arcellx is a biotechnology business based in the US. Arcellx shares (ACLX) are listed on the NASDAQ and all prices are listed in US Dollars. Arcellx employs 78 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Arcellx stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ACLX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Finder Award
Finder Award
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Arcellx stock price (NASDAQ: ACLX)
Use our graph to track the performance of ACLX stocks over time.Arcellx shares at a glance
Information last updated 2023-03-25.
| Latest market close | $29.33 |
|---|---|
| 52-week range | $6.04 - $35.26 |
| 50-day moving average | $30.12 |
| 200-day moving average | $23.45 |
| Wall St. target price | $38.88 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.69 |
Buy Arcellx stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 6 of 6
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Arcellx stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Arcellx price performance over time
Historical closes compared with the close of $29.33 from 2023-03-24
| 1 week (2023-03-20) | -1.25% |
|---|---|
| 1 month (2023-02-27) | 4.53% |
| 3 months (2022-12-27) | -0.98% |
| 6 months (2022-09-27) | 55.19% |
| 1 year (2022-03-25) | 80.38% |
|---|---|
| 2 years (2021-03-23) | N/A |
| 3 years (2020-03-23) | N/A |
| 5 years (2018-03-23) | N/A |
Arcellx financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -44.57% |
| Return on equity TTM | -93.13% |
| Profit margin | 0% |
| Book value | $5.39 |
| Market capitalisation | $1.4 billion |
TTM: trailing 12 months
Arcellx share dividends
We're not expecting Arcellx to pay a dividend over the next 12 months.
Arcellx overview
Arcellx, Inc. , a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent SparX proteins targeting BCMA to treat r/r MM; ACLX-002 and ACLX-003 for treating r/r acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS); and other AML/MDS product candidates, as well as solid tumor programs. It has strategic alliance with Kite to co-develop and co-commercialize CART-ddBCMA. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc.
Frequently asked questions
What percentage of Arcellx is owned by insiders or institutions?Currently 16.841% of Arcellx shares are held by insiders and 100.897% by institutions. How many people work for Arcellx?
Latest data suggests 78 work at Arcellx. When does the fiscal year end for Arcellx?
Arcellx's fiscal year ends in December. Where is Arcellx based?
Arcellx's address is: 25 West Watkins Mill Road, Gaithersburg, MD, United States, 20878 What is Arcellx's ISIN number?
Arcellx's international securities identification number is: US03940C1009
More guides on Finder
-
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
-
How to Buy Gold Stocks
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
-
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
-
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
Ask an Expert